Records containing: Therapy-Related Myelodysplastic Syndrome

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-03-13
Phase II Study of Clinical Efficacy of Venetoclax in Combination With Azacitidine in Patients With Therapy Related Myelodysplastic Syndrome (t-MDS)
CLINICAL_TRIALS study record update · 2026-03-12
A Phase I Study of Venetoclax in Combination With Cytotoxic Chemotherapy, Including Calaspargase Pegol, for Children, Adolescents and Young Adults With High-Risk Hematologic Malignancies
CLINICAL_TRIALS study record update · 2026-03-10
Phase I Trial of the Combination of Ibrutinib and Lenalidomide for the Treatment of Patients With MDS Who Have Failed or Refuse Standard Therapy
CLINICAL_TRIALS study record update · 2026-02-12
Phase I/II of Venetoclax in Combination With Azacitidine in Treatment Naïve and Relapse Refractory High Risk MDS Individuals"
CLINICAL_TRIALS study record update · 2026-01-12
A Phase I/II Study of Venetoclax in Combination With Azacitidine in Relapsed/Refractory High-Risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-11-06
Personalized NK Cell Therapy in CBT
CLINICAL_TRIALS study record update · 2025-09-26
A Randomized Phase III Trial of Patients With Advanced Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation With Either Orca-T, a T-cell-Depleted Graft With Additional Infusion of Conventional T Cells and Regulatory T Cells, or Standard-of-Care Allogeneic Graft
CLINICAL_TRIALS study record update · 2023-11-07
NK Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies
CLINICAL_TRIALS study record update · 2023-06-28
Cord Blood Ex-Vivo MSC Expansion Plus Fucosylation to Enhance Homing and Engraftment
CLINICAL_TRIALS study record update · 2023-06-26
Post-Transplant Use of Irradiated Haplo-Allogeneic Cells
CLINICAL_TRIALS study record update · 2023-04-04
Phase II Study of Clofarabine and High-Dose Melphalan Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation for Myelodysplasia or Acute Leukemia in Remission
CLINICAL_TRIALS study record update · 2023-02-16
Phase I Clinical Trial Using an Engineered Peripheral Blood Graft for Haploidentical Transplantation
CLINICAL_TRIALS study record update · 2020-06-09
Phase II Trial of Vosaroxin in Combination With Infusional Cytarabine in Patients With Untreated AML
CLINICAL_TRIALS study record update · 2020-02-11
Natural Killer Cells in Allogeneic Cord Blood Transplantation